A study to look at how safe different doses of a new medicine (GDC-5780) were
A Phase I, Randomized, Double-Blind, Single Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of GDC-5780 in Healthy Subjects
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com